Tango Therapeutics, Inc. (TNGX) Net margin 2020–2025
Tango Therapeutics, Inc. (TNGX) net profit margin by fiscal year — reported net income divided by reported revenue.
-162.9%FY2025 · since FY2020: -678.8% → -162.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -162.9% | +146.9 pp |
| FY2024 | -309.7% | -31.2 pp |
| FY2023 | -278.5% | +156.6 pp |
| FY2022 | -435.1% | -277.9 pp |
| FY2021 | -157.2% | +521.6 pp |
| FY2020 | -678.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TNGX financial trends
TNGX RevenueTNGX Net incomeTNGX Gross profitTNGX Gross marginTNGX Operating incomeTNGX Operating marginTNGX Operating cash flowTNGX Free cash flowTNGX Capital expendituresTNGX Return on equityTNGX Stock buybacksTNGX Dividends paidTNGX Total assetsTNGX Total liabilitiesTNGX Shareholders’ equityTNGX overview →